211 related articles for article (PubMed ID: 34563808)
1. Cannabidiol (CBD) and cognition in epilepsy.
Gaston TE; Martin RC; Szaflarski JP
Epilepsy Behav; 2021 Sep; 124():108316. PubMed ID: 34563808
[TBL] [Abstract][Full Text] [Related]
2. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
Del Pozo A; Barker-Haliski M
Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy.
Martin RC; Gaston TE; Thompson M; Ampah SB; Cutter G; Bebin EM; Szaflarski JP
Epilepsy Behav; 2019 Aug; 97():105-110. PubMed ID: 31220785
[TBL] [Abstract][Full Text] [Related]
5. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.
Patra PH; Barker-Haliski M; White HS; Whalley BJ; Glyn S; Sandhu H; Jones N; Bazelot M; Williams CM; McNeish AJ
Epilepsia; 2019 Feb; 60(2):303-314. PubMed ID: 30588604
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
9. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
[TBL] [Abstract][Full Text] [Related]
11. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development.
Samanta D
Epilepsy Behav; 2022 Mar; 128():108577. PubMed ID: 35151190
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.
Talwar A; Estes E; Aparasu R; Reddy DS
Exp Neurol; 2023 Jan; 359():114238. PubMed ID: 36206805
[TBL] [Abstract][Full Text] [Related]
13. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid treatments in epilepsy and seizure disorders.
Devinsky O; Jones NA; Cunningham MO; Jayasekera BAP; Devore S; Whalley BJ
Physiol Rev; 2024 Apr; 104(2):591-649. PubMed ID: 37882730
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures.
Reddy DS; Mbilinyi RH; Ramakrishnan S
Exp Neurol; 2023 Jan; 359():114240. PubMed ID: 36216124
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Osborne AL; Solowij N; Weston-Green K
Neurosci Biobehav Rev; 2017 Jan; 72():310-324. PubMed ID: 27884751
[TBL] [Abstract][Full Text] [Related]
17. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy.
Nenert R; Allendorfer JB; Bebin EM; Gaston TE; Grayson LE; Houston JT; Szaflarski JP
Epilepsy Behav; 2020 Nov; 112():107297. PubMed ID: 32745959
[TBL] [Abstract][Full Text] [Related]
19. Use of cannabidiol in the treatment of epilepsy.
Mazurkiewicz-Bełdzińska M; Zawadzka M
Neurol Neurochir Pol; 2022; 56(1):14-20. PubMed ID: 35211946
[TBL] [Abstract][Full Text] [Related]
20. Molecular Targets of Cannabidiol in Neurological Disorders.
Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
